Pneumocystis pneumonia in a patient treated with alemtuzumab for relapsing multiple sclerosis
We report a patient who developed PJP two months after receiving the first course of Lemtrada, and fully recovered after receiving cotrimoxazole treatment. We should remain vigilant of opportunistic infections in patients who develop pneumonitis and evaluate the need for PJP prophylaxis during Lemtrada treatment.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Chronic Leukemia | Chronic Lymphocytic Leukemia | Leukemia | Multiple Sclerosis | Neurology | Pneumonia